Host stress drives tolerance and persistence: The bane of anti-microbial therapeutics
Cell Host & Microbe · 2024-06 · 32 (6) · 852-862
DOI: 10.1016/j.chom.2024.04.019 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Host & Microbe, 2024-06. Verfasst von Sophie Helaine und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Harvard Medical School, Boston, MA, USA. Electronic address: sophie_helaine@hms.harvard.edu. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Bacteria. Die Arbeit wurde bisher 101-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institutes of Health, Burroughs Wellcome Fund.
Abstract (Originalsprache)
Antibiotic resistance, typically associated with genetic changes within a bacterial population, is a frequent contributor to antibiotic treatment failures. Antibiotic persistence and tolerance, which we collectively term recalcitrance, represent transient phenotypic changes in the bacterial population that prolong survival in the presence of typically lethal concentrations of antibiotics. Antibiotic recalcitrance is challenging to detect and investigate-traditionally studied under in vitro conditions, our understanding during infection and its contribution to antibiotic failure is limited. Recently, significant progress has been made in the study of antibiotic-recalcitrant populations in pathogenic species, including Mycobacterium tuberculosis, Staphylococcus aureus, Salmonella enterica, and Yersiniae, in the context of the host environment. Despite the diversity of these pathogens and infection models, shared signals and responses promote recalcitrance, and common features and vulnerabilities of persisters and tolerant bacteria have emerged. These will be discussed here, along with progress toward developing therapeutic interventions to better treat recalcitrant pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Harvard Medical School, Boston, MA, USA. Electronic address: sophie_helaine@hms.harvard.edu.
- Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC, USA. Electronic address: brian_conlon@med.unc.edu.
- W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address: kdavi140@jhu.edu.
- Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA. Electronic address: dgr8@cornell.edu.
Förderung
- NIAID NIH HHS
- National Institutes of Health
- Burroughs Wellcome Fund
Zitieren
APA
Helaine, S., Conlon, B. P., Davis, K. M., & Russell, D. G. (2024). Host stress drives tolerance and persistence: The bane of anti-microbial therapeutics. Cell Host & Microbe, 32(6), 852-862. https://doi.org/10.1016/j.chom.2024.04.019
Vancouver
Helaine S, Conlon BP, Davis KM, Russell DG. Host stress drives tolerance and persistence: The bane of anti-microbial therapeutics. Cell Host & Microbe. 2024;32(6):852-862. doi:10.1016/j.chom.2024.04.019
BibTeX
@article{Helaine2024,
author = {Helaine, Sophie and Conlon, Brian P and Davis, Kimberly M and Russell, David G},
title = {Host stress drives tolerance and persistence: The bane of anti-microbial therapeutics},
journal = {Cell Host & Microbe},
year = {2024},
volume = {32},
number = {6},
pages = {852--862},
doi = {10.1016/j.chom.2024.04.019}
}
EUVIMED